TETRAPHASE PHARMACEUTICALS I

CUSIP: 88165N105 Class: COMMON STOCK

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2017
Shares 160,908 Value ($000) $1,014 Avg Close — Range —
Q2 2017
Shares 300,000 Value ($000) $2,139 Avg Close — Range —
Q1 2017
Shares 300,000 Value ($000) $2,757 Avg Close — Range —
Q4 2016
Shares 300,000 Value ($000) $1,209 Avg Close — Range —
Q3 2016
Shares 300,000 Value ($000) $1,149,000 Avg Close — Range —
Q2 2016
Shares 300,000 Value ($000) $1,290 Avg Close — Range —
Q1 2016
Shares 300,000 Value ($000) $1,389 Avg Close — Range —
Q4 2015
Shares 225,000 Value ($000) $2,257 Avg Close — Range —
Q3 2015
Shares 225,000 Value ($000) $1,679 Avg Close — Range —
Q2 2015
Shares 107,400 Value ($000) $5,095 Avg Close — Range —
Q1 2015
Shares 122,000 Value ($000) $4,470 Avg Close — Range —